Joel P. Berger

15.6k citations
93 papers · 11.9k · 5 hit papers · h-index 46

Impact in

  • Biochemistry top 0.2%
    • Eicosanoids and Hypertension Pharmacology
  • Physiology top 0.2%
    • Adipose Tissue and Metabolism

Papers in

    • Peroxisome Proliferator-Activated Receptors 61
    • Metabolism, Diabetes, and Cancer 26
    • Receptor Mechanisms and Signaling 5
    • Adipose Tissue and Metabolism 43

Joel P. Berger

93 papers receiving 11.6k citations

Joel P. Berger's Hit Papers

International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors 2006 · 816 citations
8160+8+16Years since publication50010001.5k2.0k

Peers

Joel P. Berger
Comparison fields: 5 of 131
  • Biochemistry 1.0k
  • Physiology 3.3k
  • Molecular Biology 7.0k
  • Epidemiology 2.4k
  • Endocrinology, Diabetes and Metabolism 1.1k
Replace Barry M. Forman with:
Barry M. Forman United States
Makoto Makishima Japan
David Bernlohr United States
Thomas W. Doebber United States
David Y. Hui United States
Manuel Vázquez‐Carrera Spain
Dieter Lütjohann Germany
Rolf K. Berge Norway
Joyce J. Repa United States
Nada A. Abumrad United States
Joel P. Berger relative to Barry M. Forman United States Barry M. Forman's profile →
Citations per field
00.5×1.5×
Barry M. Forman · 1×
Citations per year

Countries citing papers authored by Joel P. Berger

Since Specialization
Citations

This map shows the geographic impact of Joel P. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel P. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel P. Berger more than expected).

Fields of papers citing papers by Joel P. Berger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel P. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel P. Berger. The network helps show where Joel P. Berger may publish in the future.

Co-authors

The 25 scholars most cited alongside Joel P. Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joel P. Berger Line = papers co-authored together Joel P. Berger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The Mechanisms of Action of PPARs
Hit paper breakdown →
20022162
2
Complex Distribution, Not Absolute Amount of Adiponectin, Correlates with Thiazolidinedione-mediated Improvement in Insulin Sensitivity
Hit paper breakdown →
2004980
3
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Hit paper breakdown →
2006816
4
Integrated Genomic and Proteomic Analyses of Gene Expression in Mammalian Cells
Hit paper breakdown →
2004648
5
PPARs: therapeutic targets for metabolic disease
Hit paper breakdown →
2005588
6 2002498
7 1996340
8 2007314
9 2003273
10 2000270
11 2008246
12 1996239
13 2001210
14 2001175
15 2000170
16 2001160
17 2002158
18 2002156
19 2003137
20 2008134

About Joel P. Berger

Joel P. Berger is a scholar working on Molecular Biology, Physiology, Epidemiology, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 93 papers that have together received 11.9k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (61 papers), Adipose Tissue and Metabolism (43 papers), Metabolism, Diabetes, and Cancer (26 papers), Adipokines, Inflammation, and Metabolic Diseases (17 papers), Eicosanoids and Hypertension Pharmacology (13 papers), Inflammatory mediators and NSAID effects (7 papers), Hormonal Regulation and Hypertension (6 papers) and Receptor Mechanisms and Signaling (5 papers). The work is most often cited by research in Biochemistry (1.0k citations), Physiology (3.3k citations), Molecular Biology (7.0k citations), Epidemiology (2.4k citations) and Endocrinology, Diabetes and Metabolism (1.1k citations). Joel P. Berger has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include David E. Moller, Taro E. Akiyama, Peter T. Meinke, Alex Elbrecht, Philipp E. Scherer, John A. Wagner, Karen L. MacNaul, Tom Doebber, Michael W. Rajala and Margaret Wu. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Journal of Biological Chemistry, European Journal of Pharmacology and Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact